Mucin glycoprotein disulfide bond

"Mucus glycoprotein disulfide bonds" refers to **disulfide bonds within and between gel-forming mucin glycoproteins**, key components of mucus. This phrase describes a structural feature, not a single molecular target or receptor, but these bonds are essential for the physical properties and biological functions of mucus in health and disease. Disulfide bonds are covalent links formed between cysteine residues of **gel-forming mucin glycoproteins**, such as MUC2 and MUC5B, which are the **major structural components of mucus gels on mucosal surfaces**[1][4][5][6]. These bonds are essential for forming and stabilizing large polymeric and aggregated mucin networks, imparting gel-like rheological properties crucial for **protecting epithelial surfaces, trapping pathogens, and regulating mucosal barrier permeability**[1][3][5][6]. Disulfide bonds can be intermolecular or intramolecular, and their reduction (by agents like N-acetylcysteine or dithiothreitol) breaks down the aggregate structure, transforming the mucus into less viscous forms[3][5][6]. Targeting disulfide bonds is a strategy for mucolytic therapy in diseases such as cystic fibrosis, but disrupting them excessively may compromise mucosal defense and increase infection risk[5][6]. As a structural motif, disulfide bonds themselves are not considered standalone therapeutic targets (such as receptors or enzymes)—rather, they are critical features within the mucin glycoproteins that are sometimes indirectly targeted by drugs[3][5][6]. Note: This entry describes a **structural feature, not a standalone molecule or protein target**. For structured drug targeting, the relevant canonical targets are specific mucins (e.g., "Mucin-2" for MUC2), not the disulfide bonds per se.

Other names

Mucin disulfide bondMucus disulfide cross-linkMucin S-S bond

Reduction of disulfide bonds in mucins disrupts mucus gel structure, leading to decreased viscosity or altered barrier function[3][5][6].